Helen Parfrey

7.6k total citations
51 papers, 1.6k citations indexed

About

Helen Parfrey is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Helen Parfrey has authored 51 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Helen Parfrey's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Inhalation and Respiratory Drug Delivery (6 papers). Helen Parfrey is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (37 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Inhalation and Respiratory Drug Delivery (6 papers). Helen Parfrey collaborates with scholars based in United Kingdom, United States and Australia. Helen Parfrey's co-authors include Edwin R. Chilvers, Athol U. Wells, Toby M. Maher, Andreas V. Hadjinicolaou, Muhammad K Nisar, David A. Lomas, Orion P. Twentyman, Elisabetta Renzoni, Doris M. Rassl and Andrew J.K. Östör and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Helen Parfrey

48 papers receiving 1.6k citations

Peers

Helen Parfrey
David G. Morris United States
Danielle Antin‐Ozerkis United States
Bridget McGarry United States
Masahide Mori Japan
Kazuhisa Konishi Japan
Antje Moeller Canada
Louis J. Vuga United States
Susan Mathai United States
Matthew Ullenbruch United States
Y Fukuda Japan
David G. Morris United States
Helen Parfrey
Citations per year, relative to Helen Parfrey Helen Parfrey (= 1×) peers David G. Morris

Countries citing papers authored by Helen Parfrey

Since Specialization
Citations

This map shows the geographic impact of Helen Parfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Parfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Parfrey more than expected).

Fields of papers citing papers by Helen Parfrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Parfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Parfrey. The network helps show where Helen Parfrey may publish in the future.

Co-authorship network of co-authors of Helen Parfrey

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Parfrey. A scholar is included among the top collaborators of Helen Parfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Parfrey. Helen Parfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Maher, Toby M., Peter Saunders, Fernando Zanghelini, et al.. (2024). Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT. SHILAP Revista de lepidopterología. 1–68. 4 indexed citations
3.
Allen, Richard J., Olivia C. Leavy, Nicholas M. Selby, et al.. (2023). Classifying the unclassifiable—a Delphi study to reach consensus on the fibrotic nature of diseases. QJM. 116(6). 429–435. 3 indexed citations
4.
Spencer, Lisa, et al.. (2020). Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019. ERJ Open Research. 7(1). 187–2020. 21 indexed citations
5.
Miranda, Elena, Rebecca Dunmore, Doris M. Rassl, et al.. (2020). Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects. Thorax. 75(9). 754–763. 30 indexed citations
6.
Thillai, Muhunthan, Abraham Samuel Babu, Helen Parfrey, et al.. (2020). Antifibrotic Persistence in Idiopathic Pulmonary Fibrosis: A Real-World Experience of 447 Patients. A3058–A3058. 1 indexed citations
7.
Fletcher, Sophie, Mark G. Jones, Elisabetta Renzoni, et al.. (2018). Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice. ERJ Open Research. 4(4). 49–2018. 26 indexed citations
8.
9.
10.
Tatler, Amanda L., Anthony Habgood, Joanne Porte, et al.. (2016). Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 Expression. Journal of Biological Chemistry. 291(18). 9540–9553. 24 indexed citations
11.
Fiddler, Christine, Helen Parfrey, Andrew S. Cowburn, et al.. (2016). The Aminopeptidase CD13 Induces Homotypic Aggregation in Neutrophils and Impairs Collagen Invasion. PLoS ONE. 11(7). e0160108–e0160108. 15 indexed citations
12.
Tatler, Amanda L., Amanda Goodwin, Olumide B. Gbolahan, et al.. (2016). Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis. PLoS ONE. 11(8). e0158047–e0158047. 33 indexed citations
13.
Reddy, Taryn, Masaki Tominaga, David M. Hansell, et al.. (2012). Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. European Respiratory Journal. 40(2). 377–385. 248 indexed citations
14.
Migliore, Marcello, et al.. (2012). A hybrid single-trocar VATS technique for extracorporeal wedge biopsy of the lingula in patients with diffuse lung disease. Updates in Surgery. 64(3). 223–225. 3 indexed citations
15.
Jenkins, Gísli, Andrew D. Blanchard, Zea Borok, et al.. (2011). In search of the fibrotic epithelial cell: opportunities for a collaborative network. Thorax. 67(2). 179–182. 13 indexed citations
16.
Hadjinicolaou, Andreas V., Muhammad K Nisar, Sanjeev Bhagat, et al.. (2011). Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review. Lara D. Veeken. 50(12). 2297–2305. 96 indexed citations
17.
Irving, James A., Ugo Ekeowa, Didier Belorgey, et al.. (2011). The Serpinopathies. Methods in enzymology on CD-ROM/Methods in enzymology. 501. 421–466. 28 indexed citations
18.
Parfrey, Helen, Judith Babar, Christine Fiddler, & Edwin R. Chilvers. (2010). Idiopathic pulmonary fibrosis in a Christmas Island nuclear test veteran. BMJ Case Reports. 2010. bcr0620103102–bcr0620103102. 3 indexed citations
19.
Parfrey, Helen. (2003). α1-Antitrypsin deficiency, liver disease and emphysema. The International Journal of Biochemistry & Cell Biology. 35(7). 1009–1014. 53 indexed citations
20.
Devlin, Glyn L., Helen Parfrey, Deborah J. Tew, David A. Lomas, & Stephen Bottomley. (2001). Prevention of Polymerization of M and Z α1-Antitrypsin ( α1-AT) with Trimethylamine N -Oxide: Implications for the Treatment of α1-AT Deficiency. American Journal of Respiratory Cell and Molecular Biology. 24(6). 727–732. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David G. Morris Breakdown of academic impact, for papers by Danielle Antin‐Ozerkis Breakdown of academic impact, for papers by Bridget McGarry Breakdown of academic impact, for papers by Masahide Mori Breakdown of academic impact, for papers by Kazuhisa Konishi Breakdown of academic impact, for papers by Antje Moeller Breakdown of academic impact, for papers by Louis J. Vuga Breakdown of academic impact, for papers by Susan Mathai Breakdown of academic impact, for papers by Matthew Ullenbruch Breakdown of academic impact, for papers by Y Fukuda
Rankless by CCL
2026